C3orf22
gene geneOn this page
Also known as MGC34728
Summary
C3orf22 (chromosome 3 open reading frame 22, HGNC:28534) is a protein-coding gene on chromosome 3q21.3, encoding Uncharacterized protein C3orf22 (Q8N5N4).
Located in cytoplasm.
Source: NCBI Gene 152065 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 66 total
- MANE Select transcript:
NM_152533
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28534 |
| Approved symbol | C3orf22 |
| Name | chromosome 3 open reading frame 22 |
| Location | 3q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC34728 |
| Ensembl gene | ENSG00000180697 |
| Ensembl biotype | protein_coding |
| Entrez | 152065 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 nonsense_mediated_decay
ENST00000318225, ENST00000505070
RefSeq mRNA: 1 — MANE Select: NM_152533
NM_152533
CCDS: CCDS3040
Canonical transcript exons
ENST00000318225 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001218978 | 126551997 | 126552122 |
| ENSE00001218993 | 126549692 | 126550078 |
| ENSE00001219000 | 126553302 | 126553430 |
| ENSE00003842761 | 126558627 | 126558932 |
Expression profiles
Bgee: expression breadth broad, 25 present calls, max score 91.93.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0408 / max 32.4781, expressed in 3 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 44353 | 0.0241 | 3 |
| 44354 | 0.0064 | 3 |
| 44352 | 0.0061 | 3 |
| 44355 | 0.0042 | 2 |
Top tissues by expression
203 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 91.93 | gold quality |
| left testis | UBERON:0004533 | 91.20 | gold quality |
| sperm | CL:0000019 | 88.43 | gold quality |
| testis | UBERON:0000473 | 87.61 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.58 | silver quality |
| adult organism | UBERON:0007023 | 62.31 | silver quality |
| pancreatic ductal cell | CL:0002079 | 60.43 | silver quality |
| endothelial cell | CL:0000115 | 58.93 | gold quality |
| buccal mucosa cell | CL:0002336 | 56.59 | gold quality |
| vena cava | UBERON:0004087 | 56.24 | gold quality |
| kidney epithelium | UBERON:0004819 | 55.20 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 54.70 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| ileal mucosa | UBERON:0000331 | 52.87 | silver quality |
| tibialis anterior | UBERON:0001385 | 51.20 | silver quality |
| oocyte | CL:0000023 | 51.14 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| deltoid | UBERON:0001476 | 49.77 | gold quality |
| cauda epididymis | UBERON:0004360 | 49.25 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| quadriceps femoris | UBERON:0001377 | 46.72 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 46.62 | gold quality |
| synovial joint | UBERON:0002217 | 46.45 | gold quality |
| vastus lateralis | UBERON:0001379 | 45.40 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 45.04 | gold quality |
| muscle tissue | UBERON:0002385 | 44.42 | gold quality |
| amniotic fluid | UBERON:0000173 | 44.12 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 44.09 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.30 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
8 targeting C3orf22, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-7109-5P | 99.18 | 66.13 | 1057 |
| HSA-MIR-4651 | 99.06 | 67.57 | 2002 |
| HSA-MIR-608 | 98.93 | 67.83 | 2013 |
| HSA-MIR-4763-5P | 98.75 | 63.89 | 854 |
| HSA-MIR-548S | 98.50 | 67.17 | 1213 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | BC048671 | ENSMUSG00000049694 |
| rattus_norvegicus | C4h3orf22 | ENSRNOG00000025934 |
Protein
Protein identifiers
Uncharacterized protein C3orf22 — Q8N5N4 (reviewed: Q8N5N4)
All UniProt accessions (1): Q8N5N4
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N5N4-1 | 1 | yes |
| Q8N5N4-2 | 2 |
RefSeq proteins (1): NP_689746* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR038782 | C3orf22 | Family |
UniProt features (2 total): chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N5N4-F1 | 67.00 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 12 (showing top):
chr3q21, GSE13522_WT_VS_IFNG_KO_SKIN_DN, GSE14026_TH1_VS_TH17_UP, GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN, DESCARTES_MAIN_FETAL_THYMIC_EPITHELIAL_CELLS, GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN, GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN, GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN, GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP, GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN, GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN, GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
116 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C3orf22 | RNASE12 | Q5GAN4 | 621 |
| C3orf22 | C12orf56 | Q8IXR9 | 620 |
| C3orf22 | SMIM17 | P0DL12 | 608 |
| C3orf22 | SH2D7 | A6NKC9 | 596 |
| C3orf22 | C1orf167 | Q5SNV9 | 591 |
| C3orf22 | CC2D2B | Q6DHV5 | 591 |
| C3orf22 | C22orf42 | Q6IC83 | 590 |
| C3orf22 | ANKRD62 | A6NC57 | 583 |
| C3orf22 | SPDYE4 | A6NLX3 | 581 |
| C3orf22 | CLPSL1 | A2RUU4 | 578 |
| C3orf22 | EPCIP | Q9NYP8 | 576 |
| C3orf22 | RD3L | P0DJH9 | 574 |
| C3orf22 | SMIM21 | Q3B7S5 | 572 |
| C3orf22 | MGAT4D | A6NG13 | 544 |
| C3orf22 | SPATA12 | Q7Z6I5 | 541 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0B4J1N3, A0A1B0GTK4, A0A1B0GTR0, A0JNL8, A2RUT3, A4IFR0, C9JUS6, D3ZKM3, E9PXB6, F2Z3F1, O70899, O71302, O93195, O95411, P03165, P04610, P0C7M3, P12912, P13206, P20976, P20977, P29560, P47939, P47940, P69714, Q02919, Q08648, Q1RN00, Q1WG82, Q5PR19, Q66669, Q67923, Q69027, Q69604, Q6PDA7, Q6UWK7, Q80IU5, Q80IU8, Q8N5N4, Q913A9
Diamond homologs: Q32PB5, Q8C5S3, Q8N5N4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
66 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 60 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1350 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:126551995:A:AC | donor_gain | 1.0000 |
| 3:126551995:AC:A | donor_gain | 1.0000 |
| 3:126551996:C:CC | donor_gain | 1.0000 |
| 3:126551996:CC:C | donor_gain | 1.0000 |
| 3:126551996:CCCT:C | donor_gain | 1.0000 |
| 3:126553315:T:TA | donor_gain | 1.0000 |
| 3:126553426:CATGG:C | acceptor_gain | 1.0000 |
| 3:126553427:ATGG:A | acceptor_gain | 1.0000 |
| 3:126553428:TGG:T | acceptor_gain | 1.0000 |
| 3:126553429:GG:G | acceptor_gain | 1.0000 |
| 3:126553429:GGC:G | acceptor_loss | 1.0000 |
| 3:126553431:C:CC | acceptor_gain | 1.0000 |
| 3:126553432:T:G | acceptor_loss | 1.0000 |
| 3:126541721:T:A | acceptor_gain | 0.9900 |
| 3:126541724:C:A | acceptor_gain | 0.9900 |
| 3:126541731:AG:A | acceptor_gain | 0.9900 |
| 3:126541732:GG:G | acceptor_gain | 0.9900 |
| 3:126541732:GGA:G | acceptor_gain | 0.9900 |
| 3:126541732:GGACC:G | acceptor_gain | 0.9900 |
| 3:126551990:GACTT:G | donor_loss | 0.9900 |
| 3:126551991:ACTTA:A | donor_loss | 0.9900 |
| 3:126551992:CTTAC:C | donor_loss | 0.9900 |
| 3:126551994:T:TG | donor_loss | 0.9900 |
| 3:126551995:A:C | donor_loss | 0.9900 |
| 3:126552122:CCT:C | acceptor_loss | 0.9900 |
| 3:126552123:C:CG | acceptor_loss | 0.9900 |
| 3:126552124:TGCAA:T | acceptor_loss | 0.9900 |
| 3:126553296:CCGCA:C | donor_loss | 0.9900 |
| 3:126553297:CGCAC:C | donor_loss | 0.9900 |
| 3:126553299:CACCT:C | donor_loss | 0.9900 |
AlphaMissense
897 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:126549964:G:C | F110L | 0.974 |
| 3:126549964:G:T | F110L | 0.974 |
| 3:126549966:A:G | F110L | 0.974 |
| 3:126549965:A:G | F110S | 0.903 |
| 3:126552014:C:A | R66S | 0.899 |
| 3:126552014:C:G | R66S | 0.899 |
| 3:126552027:A:G | L62S | 0.899 |
| 3:126553310:A:C | F27L | 0.898 |
| 3:126553310:A:T | F27L | 0.898 |
| 3:126553312:A:G | F27L | 0.898 |
| 3:126549980:A:G | L105S | 0.890 |
| 3:126552009:A:G | I68T | 0.888 |
| 3:126549993:A:G | W101R | 0.878 |
| 3:126549993:A:T | W101R | 0.878 |
| 3:126549991:C:A | W101C | 0.877 |
| 3:126549991:C:G | W101C | 0.877 |
| 3:126553322:A:C | F23L | 0.872 |
| 3:126553322:A:T | F23L | 0.872 |
| 3:126553324:A:G | F23L | 0.872 |
| 3:126549969:G:T | R109S | 0.870 |
| 3:126549989:T:A | E102V | 0.868 |
| 3:126549965:A:C | F110C | 0.858 |
| 3:126552035:C:A | Q59H | 0.848 |
| 3:126552035:C:G | Q59H | 0.848 |
| 3:126552122:C:A | R30S | 0.846 |
| 3:126552122:C:G | R30S | 0.846 |
| 3:126549988:T:A | E102D | 0.826 |
| 3:126549988:T:G | E102D | 0.826 |
| 3:126552015:C:A | R66M | 0.821 |
| 3:126549966:A:C | F110V | 0.813 |
dbSNP variants (sampled 300 via entrez): RS1000045188 (3:126545734 T>C), RS1000072177 (3:126532101 T>G), RS1000190774 (3:126539558 T>TGC), RS1000300113 (3:126532789 A>G), RS1000316401 (3:126550122 G>A), RS1000342153 (3:126560614 T>C), RS1000395911 (3:126560926 C>A,T), RS1000486227 (3:126532537 A>G), RS1000533511 (3:126544234 C>T), RS1000549130 (3:126537597 C>T), RS1000843897 (3:126549878 C>A,G,T), RS1000915339 (3:126555639 T>G), RS1000977417 (3:126537777 A>G), RS1000996474 (3:126543861 C>T), RS1001045561 (3:126544115 C>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002393_246 | Monocyte count | 7.000000e-11 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005091 | monocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs1054097 | C3orf22, CHST13 | 0.00 | 0 |
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 2 |
| Aflatoxin B1 | decreases expression, increases methylation | 2 |
| terbufos | increases methylation | 1 |
| tebuconazole | decreases expression | 1 |
| Grape Seed Proanthocyanidins | increases expression, affects cotreatment | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Catechin | affects cotreatment, increases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Diazinon | increases methylation | 1 |
| Fonofos | increases methylation | 1 |
| Parathion | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.